Hi Reader,

Chris Wood here. Our in-depth briefing on two of the top biotech stocks in our Biotech Millionaire portfolio was a smashing success with Mauldin Economics readers.

It really is a must-see, so even if you didn’t register for it, this is your chance to watch it.

The biotech sector is on fire—and the time to take action is now. Don’t wait until it’s too late.

In this presentation, Jake and I give you all the information you need to get in on our first “Hawking Factor” opportunity... detailed description, name, ticker, everything.

We think our subscribers have a good shot at making around 1,000% when everything’s said and done. The stock is already on the rise, so don’t let the price get away from you.

I hope after you watch our briefing, you’ll log onto your brokerage account and buy at least a few shares.

And our second “Hawking Factor” stock is even hotter.

Now that we’re looking at new viral hotspots in Arizona, Florida, Oklahoma, Oregon, Texas, North and South Carolina, and Alabama—and potentially a second wave of the pandemic—many investors’ eyes are on this pioneer whose lead therapy could treat the #1 cause of COVID-19 deaths.

The stock already took a big leap of 237.3% between March 16 and April 1, but then settled back down a bit.

And there is MUCH more to come.

We estimate gains of up to 1,270% in the next 12–18 months.

It’s not too late to get in and “ride the wave,” so take a few minutes and watch this important briefing now

Chris Wood
Chief Investment Officer for Healthcare and Biotech
Mauldin Economics